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ABSTRACT 
BACKGROUND: 
 In the Indian scenario, a large percentage of tobacco abuse is in the form 
of Smokeless tobacco (ST) and the usage pattern has undergone a gradual 
change over the years with chewers becoming lesscommon.Hence, there is a 
need to reassess the epidemiology of oral cancer with respect to these recent 
tobacco product usage. 
 
AIMS: 
 This study aims to find the usage pattern of non-smoking tobacco in 
patients with oral cancer in comparison with people without cancer. 
 
MATERIALS & METHODS: 
 100 cases of established oral cancer patients with history of quid use were 
compared with 100 age matched controls with quid use but no cancer. Both 
were administered semi-structured questionnaires and data analysed with SPSS. 
RESULTS: 
 The most common age group affected by cancer was 46-55 yrs. (35%), 
mean age of presentation was 51.5 years and 31% presented with cancer at age 
<45 yrs. The mean years of exposure for tobacco quids placed in mouth was 
20.85 with significantly more quids use number, overnight usage pattern (69%) 
and placement for more than 1 hour/ usage (38%) among cases than controls. 
Other abuses like bidi (52%), cigarette (47%), alcohol (53%) and other types of 
smokeless tobacco (54%) were significantly more than in controls. Awareness 
of ill effects was lesser (53%) and abstinence was more in cases (54%) than in 
controls. 
CONCLUSION 
 The study has found that a person who has oral cancer and primarily uses 
tobacco quids tends to use it more frequently, for longer periods of time than 
controls and is more likely to consume alcohol, cigarettes and bidis on a regular 
basis.The disfigurement and loss of function caused by oral cancer, its 
treatment, the number of life years lost due to the disease and the ever growing 
incidence of Oral squamous carcinoma in our country point to the fact that we 
need to emphasise on  increasing public awareness, screening, early diagnosis 
and treatment.  
Keywords: smokeless tobacco, abuse pattern, oral cancer, quid 
 INTRODUCTION 
  Oral cavity cancer is a huge health problem in India the recent 
increase in incidence being attributed to the wide availability of a variety 
of tobacco products in India. Tobacco abuse causes an enormous social 
burden, loss of productivity and myriad of health conditions. Tobacco use 
raises the chances for cancers of the mouth, lips, nasal cavity and sinuses, 
larynx, pharynx, lungs, oesophagus, stomach, pancreas, kidney, bladder, 
uterus, cervix, colon/rectum, ovary, and acute myeloid leukaemia. 
Tobacco is smoked, kept as ‘quids’ in the oral cavity and chewed alone or 
with various additives like lime, areca nut & betel leaves.  
In the Indian scenario, a large percentage of tobacco abuse is in the 
form of Smokeless tobacco (ST). Ninety percent of oral cancers in India 
are attributable to tobacco making it the main culprit in the “Indian Oral 
Cancer” scenario. Although the causal  role of smokeless tobacco has 
been well established in Oral squamous cell carcinoma, the myriad 
varieties of tobacco products & preparations with multiple unquantified 
ingredients in India pose a challenge in ascertaining the carcinogenic 
potential of these substances and establishing a dose response 
relationship. This is compounded by abusers resorting to concurrent use 
of tobacco through smoking, alcohol, poor oral hygiene which confounds 
such quantification. 
 Given below are some of the most common forms of smokeless tobacco 
from around the world. 
TOBACCO     CONTENTS REGION 
Pan/paan/betel 
quid 
Areca nut, betel leaf, slaked lime, 
catechu, condiments, with or 
without tobacco 
India ,Southeast 
Asia, South America 
‘Khaini’ Tobacco, lime Bihar 
‘Mishri’ Burned tobacco Maharashtra 
‘Zarda’ Boiled tobacco India, Arab nations 
‘Gadakhu’ Tobacco, molasses India 
‘Mawa’ Tobacco, lime,areca India 
‘Nass’ Tobacco, ash, cotton or sesame oil Afghanistan, Pakistan, Iran, 
‘Naswar,niswar’ Tobacco, lime, indigo, cardamom, 
oil, menthol, etc 
 Asia,Iran, 
Afghanistan, 
Pakistan 
‘Shammah’ Tobacco, ash,lime Saudi Arabia 
‘Toombak’ Tobacco,soda bicarb Sudan 
  
Apart from Bidis & cigarettes, numerous tobacco products like 
gutka, tobacco flakes are marketed in attractive sachets, ubiquitous and 
cheap, all of which contributes to their highly prevalent usage in India.  
Consensus among medical workers and oncologists in 
standardising the definition of these different types of tobacco 
preparations is in process. For example, a workshop conducted in Kuala 
Lumpur recommended that “quid” be defined as “a substance, or mixture 
of substances, placed in the mouth or chewed and remaining in contact 
with the mucosa, usually containing one or both of the two basic 
ingredients, tobacco and/or areca nut, in raw or any manufactured or 
processed form.”(4) In addition to defining quid-related terminologies, 
the workshop participants set guidelines for reporting quid use among 
research subjects. They emphasised, the ingredients be outlined in detail 
so it would be possible to differentiate into three categories: 
• “Quid with areca nut without any tobacco products involving chewing 
only the areca nut or areca nut quid wrapped in betel leaf ”. 
• “Quid with tobacco products but without areca nut, including chewing 
tobacco, chewing tobacco plus lime, mishri (burned tobacco applied to 
the teeth and gums), moist snuff, dry snuff, niswar (a different kind of 
tobacco snuff ) and naas (a stronger form of niswar)”. 
• “Quid  with both areca nut and tobacco products (paan with tobacco)”. 
Areca nut & tobacco are easily identifiable and hence were chosen 
to make product categorisation simple. 
A study from India in concurrence with other smaller studies, 
concluded  paan to be the most important causative factor of smokeless 
tobacco. The usage of smokeless tobacco has undergone a gradual change 
in India. Previously tobacco flakes were chewed and spat out. Also they 
were used with betel leaves, areca nut and lime which were chewed into a 
cud and then spat out. But tobacco in the granular form and quids placed 
in one part of the oral cavity (Khaini, mawa) has emerged as a major 
form of tobacco in recent years with alarmingly high usage by younger 
age groups placing them at risk of chronic exposure. These quids when 
kept in one particular region of the buccal mucosa for prolonged periods 
put the overlying mucosa at increased risk for mutagenesis as compared 
to chewing tobacco which involves exposure of mucosa for a short time 
after which it is spat out. With this gradual but definitive change in usage 
pattern, there is a need to reassess the carcinogenic potential and 
epidemiology of “Indian oral cancer” holistically. 
Tobacco flake is one of the major forms of non-smoking tobacco 
marketed in India, usually with lime as additive. These flakes are made 
into quids and kept in the oral cavity, particularly in the tobacco alveolar 
sulcus for varying amount of time. The term used for these flakes varies 
in different parts of the world (Tobacco quids, khaini in India, moist snuff 
in United States of America)  
With more than 90% of oral cancer attributed to tobacco, the need 
to curb tobacco usage is more than ever. 
This study aims to find the usage pattern of this specific form of 
tobacco (tobacco quid or Khaini) in patients with oral cancer in 
comparison with people without cancer. 
Various parameters like years of abuse, quantum of use, co-abuse 
of other substance like bidi, cigarette, alcohol and other smokeless 
tobacco are assessed. 
Despite the advances in medical sciences over the past few 
decades, the prognosis of Oral squamous cell carcinoma remains dismal 
with the overall five year survival being 65% for T1,T2 lesions and 30% 
for more advanced T stages with survival reduced to half these numbers 
in case of node positivity. This reflects the definite incentive in early 
diagnosis. 
Various techniques like confocal microscopy, Radiolabelled 
antibodies to tumour markers, narrow band imaging, multi-wavelength 
fluorescence and reflectance technology are being designed to detect 
subclinical disease in at–risk patients to identify dysplasia. This translates 
to a necessity to define the at-risk subset of people among oral tobacco 
abusers for screening with the above mentioned technique, as screening 
the entire population of oral tobacco abusers is economically and 
logistically not feasible.  
This study will to an extent try to delineate such high risk 
population by studying the tobacco use patterns of patients with 
established oral cancer.  
 
              AIMS AND OBJECTIVES 
Primary Objectives: 
1. To find out mean years of exposure required to produce oral cancer or 
premalignant lesions 
2. To find out specific high risk abuse patterns in patients with oral 
cancer(overnight abusers, large volume abusers) 
3. To find out if the amount of tobacco used per day is significantly more in 
patients with oral malignancy 
 
Secondary objectives 
1. To find out any specific socio economic class with proclivity for high 
rates of abuse and subsequent high rates of oral malignancy 
2. To find out if alcohol and smoking tobacco co-abuse  increases the risk of 
oral cancer. 
3. To find out the level of awareness about the ill effects of tobacco among 
patients with oral cancer 
4. Ultimately to serve as a tool to define a high risk subset among people 
with  tobacco quid abuse who are at increased risk of developing oral 
cancer. 
 
 
 
 
 REVIEW OF LITERATURE: 
 
Anatomy of the oral cavity 
 
The oral cavity may be subdivided into two smaller cavities: the 
externally positioned vestibule and the internally placed oral cavity 
proper. 
1. The vestibule is the space bounded by the lips and cheeks 
anteriorly and laterally, whereas its internal boundary is formed by 
the dental arches. The ducts of the parotid glands deliver their 
secretory products into the vestibule 
2. The oral cavity proper is bounded by the teeth externally, the floor 
inferiorly, and the palates superiorly. 
At its posterior extent, the oral cavity proper is delineated from the 
oro-pharynx by an imaginary plane drawn between the palato-glossal 
folds just anterior to the palatine tonsils. 
The oral cavity anatomically includes the lips, buccal mucosa, 
gingiva, floor of mouth, anterior floor of mouth, anterior two thirds of 
tongue, hard palate and the retromolar trigone. 
  
ORAL MUCOSA 
The epithelium and underlining connective tissue (lamina propria) 
constitute the oral mucosa. If the epithelium is keratinized (or para 
keratinized), the mucosa is said to be masticatory mucosa, and if the 
epithelium is not keratinized, the mucosa is referred to as lining mucosa. 
The epithelium consists of four layers of the keratinized oral 
mucosa and the non-keratinized has the two of deeper four layers but 
does not have the two superficial final layer; it has a nonspecific 
superficial layer instead: 
 Stratum corneum 
 Stratum granulosum 
  Stratum spinosum  
 Stratum basale 
 
1. Most of oral cavity possesses lining mucosa, with the exception of 
the gingiva, hard palate, dorsal surface of the tongue, which are 
covered by masticatory mucosa. 
2. The oral cavity has areas of specialized mucosa, located mostly on 
the dorsal surface of the tongue, though present also on the soft 
palate and pharynx, where barrel-shaped intraepithelial structures 
known as taste buds function in taste perception. 
Keratinisation is the formation of Stratum corneum from the 
underlying stratum granulosum. It is not a living layer. The cells of the 
epidermis arise from the progenitor cells in the stratum basale and 
differentiate as they move to superficial layers. Non-keratinised 
epithelium may turn into keratinised epithelium when subjected to 
chemical injury or trauma. This change is called hyperkeratinisation.  
Hyperkeratinisation is more common in the nonkeratinised epithelium. 
An example is lineal aba which forms in the buccal mucosa in the region 
where the mandibular and maxillary teeth meet. Hyperkeratinisation 
slowly reverses if the inciting agent is removed. Hyperkeratinized tissue 
is also associated with the heat from smoking or hot fluids on the hard 
palate in the form of nicotinic stomatitis. 
The lamina propria is a fibrous connective tissue layer that consists of 
a network of type I and III collagen and elastin fibers in some regions. 
The main cells of the lamina propria are the fibroblasts, which are 
responsible for the production of the fibers as well as the extracellular 
matrix. 
The lamina propria, has two layers: papillary and dense. The papillary 
layer is the superficial layer, made up of loose connective tissue along 
with blood vessels and nerve tissue with the tissue comprising an equal 
amount of fibres, cells, and intercellular substance. The dense layer is the 
deeper layer of the lamina propria, composed of dense connective tissue 
with a large amount of fibres. Between the papillary layer and the deeper 
layers of the lamina propria is a capillary plexus for provision of nutrition 
to all the layers of mucosa and sends capillaries into the connective tissue 
papillae. 
 Depending on the region of the oral cavity a submucosa may or may 
not be present deep to the lamina propria. The submucosa contains loose 
connective tissue and may also contain salivary glands. 
 
LYMPHATIC DRAINAGE 
Lymphatics from the oral cavity primarily drain into the peri-facial, 
upper jugular, submandibular and sub-mental nodes and thence to the 
deep cervical nodes.The most connon sites involved in Oral malignancy 
are Level I,II,III and IV. 
 
 
 
 
 
 
 
 
 
CANCER OF THE ORAL CAVITY 
INCIDENCE 
Carcinoma of the oral cavity is the 6th most common malignancy in 
the world accounting for 30% of head and neck malignancies. In India, 
the scenario is different though with oral cancer being the first and third 
most common cancers in men and women respectively (1). Though males 
are more frequently affected than females according to worldwide and 
India statistics, some studies in India have put the ratio at one(1) implying 
the wide spread use of tobacco products in India. It has been calculated 
that the annual incidence of oral cancer in India is between 75,000 and 
80,000(2) with usual presentation in the sixth or seventh decade of life. 
ETIOLOGY AND RISK FACTORS 
TOBACCO 
 Several carcinogens have been identified in smokeless tobacco. 
The most important are N-Nitrosamine (TSNA), N- 
Nitrosonornicotine(NNN), 4-(methylnitrosamino)-1-(3-5pyridyl)-1 
butylone(NNK). During curing and fermentation of tobacco (NNK 
&NNN) are formed in large numbers from nicotine.While in Western 
countries smoking tobacco makes up the majority of tobacco use, in India 
a large proportion is accounted for by Smokeless Tobacco.  
Familial and Genetic Predisposition 
The genealogical records of the Utah (Mormon church) database; 
show lip to have the strongest familial cancer clustering followed by 
leukemia, lobular breast cancer, early melanoma, and adenocarcinomas of 
the lung in females (6). A study from south India revealed the familial 
association to be less than 1% of the total cancer in oral cavity consistent 
with autosomal inheritance (5). Copper and his colleagues, (7) in their 
study on probands of head & neck cancer patients found 31 cases of  
pulmonary and upper gastrointestinal tract  versus 10 cases in the control 
group comprising of probands  of the index patient’s partner (n=617) 
summing upto a ‘relative risk’ of 3.5 (significant) for first degree 
relatives, and of 14.6 (significant) for siblings with  smoking and drinking 
histories having no effect, implying a constitutional factor role in the 
handling of genotoxic substances. Jefferies et al (8) and Llewellyn et al 
(9) reviewed the evidence in this growing field. 
VIRAL INFECTIONS 
Viruses play a role in the aetiology of Oral cancers as well. Various 
viruses have been investigated in this context including Epstein Bar Virus 
(EBV), Human Simplex Virus-1 (HSV-1) and Human papilloma virus 
(HPV) types16 and 18 (10). The strongest association is between HPV 
and squamous cell carcinoma of the oral cavity, more so in the 
oropharynx (11). There is sufficient evidence for a causal role of HPV-16 
in this context but it is limited for HPV-18 (12). These viruses are found 
in approximately 25% of cases in India and 85.7% of cases in Taiwan 
(13). In Taiwan high risk HPV (Subtypes 16 and 18) emerged as 
independent risk factor even after adjusting for age, gender, cigarette 
smoking and low risk HPV infection. The OR for OC due to HPV-16 
(11.21) is greater than that for HPV-18 (13). In a Malaysian population, 
the OR was lower (4.3) (15). HPV is less common in cases that chewed 
quid or smoked when compared to those who had multiple sexual 
partners (13). Contracting HPV infection by practising oral sex is more 
likely in men and increases the risk of OC by 3 fold (14). HPV acts 
synergistically with betel quid chewing to cause high morbidity (13). 
HPV-16 infection is more common than HPV-18. 
Immunisation against HSV has been found to be carcinogenic due 
to the effect of dimethylbenzathracene. This may imply that herpes 
simplex virus may act as a co-carcinogen with various other carcinogens 
like tobacco and other substances. It has been postulated that there is 
generalised immunosuppression induced by smoking particularly of the 
NK cells activity, thereby favouring chronic HIV infections and carrier 
state which can lead to raised antibody titre(16) explaining high titres of 
HSV antibodies in smokers and those with head and neck cancer. 
 FUNGAL INFECTIONS 
Fungal invasion of leukoplakia is seen in some cases especially in 
nodular variety (17). This carries tremendous risk for transforming into 
malignant lesion. The link between smoking and candida infection is well 
established and is similar to the risk in HIV patients (17). Iron deficiency 
state predisposes to oral cancer as well as oral candidiasis. It seems that 
candidiasis per se does not cause oral malignancy but most probably is 
involved when multiple other causative factors are present. Enzymes 
present in candida causes nitrosation of food substances and this may lead 
to carcinogensis. 
 
DENTAL FACTORS 
 The clear association between poor oral hygiene and oral cancer 
has been well established. In addition to this there is also clear association 
between sharp, fractured teeth, prosthesis (18). But in most cases it is 
difficult to attribute a causal role to the above said factors because of the 
presence of confounding factors like nutrition, alcohol, tobacco abuse and 
socio-economic status. Further well controlled studies are needed to 
establish the role of these factors. Previous studies have demonstrated 
that a tumor may arise from the site of chronic ulceration caused by a 
broken tooth or dental prosthesis and this is the probable mechanism by 
which the above said factors may facilitate transformation. 
 
 
PATHOGENESIS 
Though the carcinogenic potential of smokeless tobacco has been 
well established, the genetic abnormalities and premalignant conditions 
differ significantly from that caused by smoking tobacco. In cases of 
smoking tobacco, long before the development of invasive cancer, 
genetic changes occur within the cells of the oral mucosa which are 
measurable. Chronic exposure to carcinogenic material damage the DNA 
over the mucosal field .This altered mucosa can extend as far as 7 cm 
from the site of malignancy. These molecular alterations may include 
amplification of oncogenes that promote tumor cell proliferation along 
with inactivation of tumor suppressor genes. This enables tumor cells to 
escape programmed cell death, grow and divide in a self-sufficient 
manner. 
Most of the oral premalignant lesions (70-80%) have changes in 
9p21 chromosome which encodes for tumor suppressor genes p16 and 
p14. These genes are inactivated by the epigenetic process of 
methylation. 
P53 mutation in oral malignancy has received much attention 
recently but it is a late occurrence in the transformation process. P53 
mutation in the margins of resected tissue during surgery correlates with 
increased rate of recurrence in the future. 
 
 
PREMALIGNANT LESIONS 
LEUKOPLAKIA 
 Leukoplakia is defined as “a white plaque that does not rub off and 
cannot be clinically identified as any other entity”. Not all leukoplakias 
are premalignant lesions. Dysplastic changes are seen in a meagre 20% 
population. But in some sites (floor of mouth, under surface of tongue) 
this is as high as 45%. There is no reliable way to correlate the clinical 
appearance of leukoplakia and the presence of dysplastic change detected 
histologically. If the leukoplakia is interspersed with erythroplakic 
component the risk of malignant transformation increases tremendously, 
termed as “erythro-leukoplakia”. 
 
ERYTHROPLAKIA 
An erythroplakia is defined as “a red lesion that cannot be 
classified as a clinical entity”. In contrast to leuokoplakia, there is a very 
high chance of dysplasia or malignancy in this condition approaching 
90%. There may be foci of keratosis which appear as speckled white 
spots in a background of flat red velvet appearance. 
 
LICHEN PLANUS 
 It is still disputed that lichen planus lesion is a premalignant lesion. 
It is a relatively common lesion and it is believed by some that the 
dysplasia or carcinoma found in patients with lichen planus may be 
coincidental. However many studies (Oral Cancer Background Papers) 
have reported high percentage of malignant transformation in patients 
with lichen planus. Since the malignant transformation is disputed, it 
would be prudent clinical practice to biopsy the lesion at the initial 
clinical presentation and monitor the patient for premalignant and 
malignant changes. 
 
  
MUCOSAL LESIONS ASSOCIATED WITH QUID 
Quid chewing habits are associated with specific oral mucosal 
lesion which can be classified into 2 broad categories: 
1. “Lesions or conditions that are diffusely outlined, involve more than 
one site or represent a widespread alteration, such as those due to 
mechanical or chemical trauma”. 
2. “Lesions that are localized to the site where quid is regularly placed. 
These lesions are equivalent to snuff-induced lesions or tobacco–lime 
user’s lesions, which arise only on the mucosa in contact with the quid”. 
 
 
BETEL CHEWER’S MUCOSA 
 Because of the traumatic effect of chewing or the direct action of 
betel quid there is a tendency for oral mucosa to desquamate and peel. 
Sometimes white tags of loose, detached tissues can be seen and also felt. 
The area underlying these loose tissues will have wrinkled or 
pseudomembranous appearance. There may also be yellow or reddish 
brown encrustations denoting the incorporation of ingredients of quid in 
the mucosa. Cheek-biting will also lead to a very similar appearance both 
clinically and histologically which should be differentiated from betel 
chewer’s mucosa. It should be noted that betel chewer’s mucosa results 
from an intentional habit while cheek biting is unintentional. Also cheek 
biting lesions occur in younger most likely in their 3rd or 4th decade of life 
while betel chewer’s mucosa occurs in those aged 50 and above. 
QUID-INDUCED LESION 
 This lesion occurs in the site of the oral mucosa where the quid is 
placed regularly. It is characterised by the following: presence of ulcers, 
thickened mucosa, colour change, scrapable/non-scrapable epithelial 
surface and wrinkled appearance. 
 
ARECA-NUT-RELATED LESION 
 This lesion in characterised by a greyish white discolouration 
which cannot be rubbed off. Histologically there may be para-keratinised 
or ortho-keratinised epithelium.  
 
PROBABILITY OF MALIGNANT CHANGE 
 The percentage of epithelia dysplasia becoming malignant is 5-18. 
Some types of epithelial dysplasia show high chances of malignant 
transformation than others but recognising the types of epithelial 
dysplasia with  malignant change has proved difficult because most cases 
are excised, instead of being followed up for malignant change. Epithelial 
dysplasia with high malignant change may show the following changes: 
(1) An erythroplakia arising from within a leukoplakia, 
 (2) verrucous appearance of the lesion  
(3) Lesions located in anatomic site such as the tongue or floor of   mouth 
where most cases of oral cancer occur  
(4) Negative history for smoking 
(5) More than one lesion.  
 
 
TIME TAKEN FOR EPITHELIAL DYSPLASIA TO UNDERGO 
MALIGNANT CHANGE 
Even though epithelial dysplasia is present around the regions of 
frank malignancy, not all arise from these areas, few may arise de novo 
from cells in the stratum basale. Silverman and colleagues (2) in their 
study noted the following “out of 257 patients with oral leukoplakia; 22 
had a diagnosis of epithelial dysplasia, the remaining 235, hyperkeratosis. 
Eight of the 22 (36.4%) with epithelial dysplasia developed carcinoma. 
Of the 107 patients with a homogeneous leukoplakic lesion and a 
diagnosis of hyperkeratosis, 6.5% developed carcinoma. However, 23.4% 
of the 128 patients with erythroplakic lesions and a diagnosis of 
hyperkeratosis were eventually diagnosed with carcinoma. The time from 
initial diagnosis of either epithelial dysplasia or hyperkeratosis to 
carcinoma ranged from 6 months to 39 years”. In another study reported 
by Lumerman and colleagues, “15.9% of 44 patients with oral epithelial 
dysplasia identified in a biopsy service developed carcinoma; the mean 
time from biopsy to cancer diagnosis was 33.6 months. Epithelial 
dysplasia has been more extensively studied in association with the 
uterine cervix than with the oral cavity. Based on clinical reviews, 
approximately 12% of cervical epithelial dysplasias progress to 
carcinoma in situ.  The estimated median time for this progression 
depends on the histologic severity of the epithelial dysplasia: 58 months 
for mild, 38 months for moderate, and 12 months for severe.  
Approximately 73% of carcinoma in situ cases evolve into full-blown 
carcinoma. The importance of this information in understanding the 
progression to oral cancer is unclear, but it is consistent with observations 
that not all oral epithelial dysplasia’s evolve into carcinoma in situ or full-
blown carcinoma and that this transition—when it does occur—takes 
months or years”. 
STAGING 
Staging of Oral malignancy is based on the TNM system according to the 
7th edition (2010) American Joint Committee on Cancer (AJCC) 
Guidelines 
Primary Tumour (T) 
TX      Primary cannot be assessed 
T0      No evidence of primary  tumor 
T1     Tumor not more than 2cm in greatest diameter 
T2      Tumour between 2 cm and 4 cm in its greatest diameter 
T3      Tumor greater than 4 cm in greatest dimension 
T4     Tumour invades adjacent structures (cortical bone, deep intrinsic     
muscles of    tongue, maxillary sinus or skin) 
 
REGIONAL LYMPH NODES (N) 
N0   No regional lymph nodes 
N1   Metastasis to single ipsilateral lymph node, 3cm or less in greatest                                                    
 dimension 
N2a   Metastasis to single ipsilateral lymph node >3cm but <6cm 
N2b Metastasis to multiple ipsilateral lymph nodes none >6cm 
N2c Metastasis to bilateral or contralateral lymph nodes none > 6cm 
N3   Metastasis in a lymph node > 6cm 
 
DISTANT METASTASIS (M) 
MX Distant metastasis cannot be assessed 
M0 No distant metastasis 
M1 Distant Metastasis 
  
 STAGE GROUPING 
Stage I     T1, N0, M0 
Stage II    T2, N0, M0 
Stage III   T3, N0, M0   or    T1-3, N1, M0 
Stage IV    T4, N0-1, M0      or    Any T, N2-3, M0    or Any T, Any N, 
M1 
The TNM classification doesn’t take into account the depth of the tumour 
which several clinicians feel correlates with the occurrence of nodal 
metastasis. A depth of four millimetres or more is said to be significant. 
 
 
 
TREATMENT 
Optimal treatment requires a multidisciplinary team including head 
& neck surgeons, reconstructive surgeons, medical oncologist and 
radiation oncologist. Speech and swallowing pathologists rehabilitate 
functions lost during multimodal therapy. Other important team members 
include dentists, prosthodontist, nutritionist and social workers. A multi-
specialty tumour board needs to be considered for advanced and recurrent 
cases.  
 
TREATMENT SELECTION FOR THE PRIMARY SITE: GENERAL 
PRINCIPLES 
For early cancer of oral cavity, either radiotherapy or surgery is 
preferred. When comparing the cure rates of the above mentioned 
modalities there is no significant difference. The selection of either 
surgery or radiotherapy depends on a large number of factors like 
availability of specialised surgical oncology units, the surgeon’s 
philosophies, patient personal preference, general condition, complication 
risk, required functional outcome, the cost and length of treatment. 
 
For more advanced lesions, combined radiotherapy and surgery is 
preferred. Post-operative radiotherapy is preferred now-a-days over pre-
operative radiotherapy because surgical complications are higher if the 
primary had been irradiated previously. Common indications for post-
operative radiotherapy of the primary includes 
• Margin positivity 
• Peri-neural invasion 
• Vascular invasion 
 
 
T1AND T2 CARCINOMA OF THE ORAL CAVITY 
Single modality treatment is adequate for T1, T2 carcinoma of the 
oral cavity. Whichever modality is chosen, treatment of the primary site 
and neck should be consistent. In planning resection the route of access, 
margin status, bone involvement and whether or not lymphatics require 
treatment should be considered. Bone involvement may require 
segmental mandibulectomy or at least a rim mandibulectomy . 
 
T3 AND T4 CARCINOMA OF ORAL CAVITY 
Multimodal therapy is usually required for T3 and T4 squamous cell 
carcinoma of oral cavity. Soft tissue defects are usually repaired with 
radial forearm, lateral thigh or rectus abdominus flap. Mandibular defects 
are managed with ostio cutaneous flap, the fibular flap being the most 
common.  
 
GENERAL PRINCIPLES OF MANAGING THE SECONDARIES IN 
THE NECK 
 It is well known that the incidence of secondary cervical nodal 
deposit increases with increasing stage of disease. For early stage of oral 
cancer, the neck is treated with the same modality as the primary (RT or 
surgery). Sometimes when the risk of secondary deposition in the neck is 
low (15%), the neck can simply be observed for occurrence of nodal 
metastasis. 
 For more advanced diseases of the neck, combined modality 
treatment is used. Indications of pre-operative neck radiotherapy includes 
• Large nodal mass 
• Fixity to carotid artery 
• Fixity to other adjacent structures 
Indications for post-operative neck radiotherapy includes 
• Multiple node positivity 
• Extra nodal involvement 
 
CHEMOTHERAPY 
 Even though radiotherapy and surgery can cure most early stage 
diseases, the prognosis when it comes to advanced diseases is dismal. In 
these advanced stages, chemotherapy is sometimes used to reduce distant 
metastasis and improve survival rates. The role of chemotherapy in these 
circumstances is still debatable. 
 Neo-adjuvant chemotherapy with combination of 5-fluorouracil 
and cisplatin showed response rate ranging from 60-90% in some studies. 
Around 20-40% showed complete clinical response (patients who 
experienced a complete clinical response have a better prognosis than 
people with partial or no response). But in multiple randomised control 
trials increase in survival rates could not be demonstrated. 
 Concomitant chemo-radiation for loco-regional disease control has 
resulted in increased disease free survival and better regional control in 
several well randomised control trials. But the most important adverse 
effect of this modality is the significant toxicity seen in many patients. 
 Adjuvant chemotherapy has yielded very discouraging results and 
its use is no longer recommended in the treatment of squamous cell 
carcinoma of oral cavity. 
 
 
NEWER TRENDS IN THE MANAGEMENT OF ORAL CAVITY 
 Monoclonal antibodies targeted at individual tumor cells are being 
used to deliver chemotherapeutic agents to the tumour. This will ensure 
high local tumor concentration of the chemotherapeutic agent and at the 
same time decreasing the chances of systemic toxicity. Added to this, 
monoclonal antibodies can be tagged with radiolabelled materials for a 
better and improved imaging of the tumor. Immunomodulators like alpha 
interferons and interleukin have been tried. 
Stereotactic radiosurgery, a new and emerging modality is being 
tried on those who had shown inadequate or no response to 
surgery/radiotherapy. Newer radiotherapy techniques like twice-daily 
radiotherapy, accelerated fractioned radiotherapy are being tried and 
these have been found to be useful in stage II & III oral malignancies. 
 
Gene therapy which involves introducing new genetic material into 
the human DNA in an attempt to inhibit oncogenes, activate tumor 
suppressor genes, activate host immune response, make the tumor more 
sensitive to chemo and radiotherapy. Even though there are no concrete 
results so far, the future of gene therapy in oral cancer remains promising.  
 
Regarding surgery, the use of osseo-integrated dental implants 
have paved way for more aggressive tumor removal without 
compromising on oral function. Neural micro-anastomosis after free flap 
have been tried to improve functional outcome. Micro-vascular free flap 
technique have led to better outcomes following large free flap transfers. 
 
 
 
PROGNOSIS:  
5 years survival rate range from 85% to 90% for stage1 and 70% 
to80% for stage 2 squamous cell carcinoma of the oral cavity. 
For T3 and T4 squamous cell carcinoma of the oral cavity, the 
survival rate is 50% to 65%. In the case of nodal metastases the survival 
drops to half of the above mentioned value (25-30%). 
 
 
 
 
 
 
 
 
 
 
 
METHODS AND METHODOLOGY 
100 Patients with established oral cancer and tobacco quid abuse 
were chosen and compared with age matched disease-free users of 
tobacco quid. 
The period of study was from May 2012 to December 2013.The cases were 
chosen from in-patients and out-patients attending the departments of Radiation 
oncology, surgical oncology and General surgery. A total of 372 cases of oral 
cancer were identified during the study period, of which 100 cases were 
selected after applying inclusion, exclusion criteria. Stage of the disease was 
found out from the case sheets in case of inpatients and medical records in case 
of out-patients. The selected subjects were subject to a semi-structured oral 
questionnaire about their non-smoking tobacco usage which included detailed 
questions about the number of times used per day, years of abuse and other 
substance abuse after obtaining informed consent. The patients were also 
provided with information sheets about the study in their native language. 
Controls were chosen from inpatients in the department of General 
surgery who were admitted for ailments other than malignancy. Controls 
were also chosen from attenders of patients who came as visitors to the 
hospital and were willing to take part in the study. The cases and controls 
were matched for of age. They were issued patients information sheets in 
their native language and informed consents was obtained in writing .The 
controls were subjected to similar oral questionnaire as was used for the 
cases. In addition the controls were subjected to a clinical oral 
examination to exclude any un-diagnosed malignant or pre-malignant 
lesions. 
 
INCLUSION CRITERIA: 
Cases:  
1-  People with histologically proven squamous muscle carcinoma of 
the oral cavity with history of tobacco quid (smokeless tobacco) 
abuse. 
2- All ages 
Control:  
1- Any person with history of tobacco quid abuse with no history of 
present or past malignancy. 
2- All ages 
 
 
 
 
EXCLUSION CRITERIA:  
Cases: 
1- Patients with established squamous muscle carcinoma of the oral 
cavity with no history of past or present Tobacco quid abuse  
( smokeless tobacco )  
2- Unstable physical condition  
3- Non-consenting subjects 
Controls: 
1- People with history of past or present malignancy anywhere in the 
body  
2- People found to have oral malignant or premalignant lesions on 
clinical examination 
2- Non-consenting individuals 
 
 
DATA COLLECTION 
Data collection was done with a predetermined oral semi-
structured questionnaire. 
 
  
DATA COLLECTION SHEET 
 
Name:                    
Age:      Sex:                  IP/OP no: 
Department: 
Diagnosis: 
Stage: 
 
Education: 
      1. Professional  2.Graduate   3.Diploma 
      4. High School   5.Middle School   6.Primary school 
      7. Illiterate 
 
 
Profession 
 1. Professional 2.Semiprofesional  3.Clerical/farmer 
          4. Skilled  5.Semi-skiled  6.Unskilled 
         7. Unemployed 
 
Years of Exposure: 
No of Quids/day: 
Overnight use:      1.Never       2.Ocassionally     3.Regularly 
Average time per Quid:  1.Less than half an hour 
                                        2. Half an hour to one hour 
                                        3. More than one hour 
Substance 1.Never 2.Occasionally 3.Regularly 
BIDI    
CIGARETTE    
ALCOHOL    
OTHER ST    
 
 
Awareness about  ill effects: 
History of abstinence: 
 
 
 
Educational status and profession were based on the modified 
Kuppusamy scale. Abstinence is said to be present if the patient or 
control had abstained for one year or more preceding the time of 
interview. 
 STATISTICAL ANALYSES: 
The data obtained was subject to statistical analysis using SPSS. 
Categorical variables were analysed with chi-square test, Continuous 
variables with t-test and Odd’s ratio was computed for relevant variables.  
 
 
 
 
 
RESULTS 
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 TABLE -1: AGE DISTRIBUTION 
Age group Cases Control 
% % 
25-35 yrs. 4 4 
36-45 yrs. 27 27 
46-55 yrs. 35 35 
56-65 yrs. 23 23 
66-75 yrs. 10 10 
>75 yrs. 1 1 
 
  
 
 
The most common age group affected by Squamous cell carcinoma of the 
oral cavity is between 46-55 years accounting for 35% of cases. Thirty one 
percent of the cases occurred in patients below the age of 45 years. 
 
 
TABLE-2: AGE – MEAN COMPARISON 
GROUP Mean age 
Case &  Control  
 
51.15 
 
 
The mean age at presentation is 51.15 years     
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TABLE-3: YEARS OF EXPOSURE 
Years of exposure       Cases      Control Total 
N % N % N % 
4-10 yrs. 8 8 28 28 36 18 
11-15 yrs. 20 20 37 37 57 28.5 
16-20 yrs. 23 23 19 19 42 21 
21-25 yrs. 24 24 8 8 32 16 
26-30 yrs.  18 18 6 6 24 12 
31-35 yrs. 5 5 2 2 7 3.5 
>35 yrs. 2 2 0 0 2 1 
Chi square value 33.8480 
Df  6 
P- value 0.00 (Significant) 
 
 
 
 
65% percent of controls were exposed to smokeless tobacco for less than 
fifteen years. 65% of cases were exposed to smokeless tobacco for more than 
fifteen years and 35% percent of cases were exposed for fifteen years or less. 
Of note is the 8% of cases who were exposed for ten years or less. 
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TABLE -5: MEAN YEARS OF EXPOSURE COMPARISON 
GROUP 
 
Mean years of 
exposure 
S.D T-test P-value 
Case 20.82 7.06  
6.20 
 
0.00 (sig.) Control  14.95 6.28 
 
 
 
 
The mean years of exposure in cases was found to be 20.82 years with a 
Standard Deviation of 7.06 years. While for the age matched controls, the mean 
years of exposure was 14.95 years with a Standard Deviation of 6.28 years. 
This difference is statistically significant (p-0.00) 
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TABLE-6: STAGING OF CANCER 
GROUP                          Staging of cancer 
1 2 3 4 
Cases  8 28 45 19 
Total % 8% 28% 45% 19% 
 
 
 
 
45% of patients presented with stage III disease. 
A total of 64% of patients presented with stage III disease and above. 
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          TABLE-7: NUMBER OF QUIDS PER DAY USAGE 
Group    Number of quid’s per day 
     <5       6-10      >10 
Cases 5 70 25 
Controls  56 37 7 
Total 61 (30.5%) 107 (53.5%) 32(16%) 
Chi square value 62.9419 
Df  2 
P- value 0.00 (significant) 
 
 
 
95% of cases were moderate (6-10 quids/day) to heavy users (>10 
quids/day). Only 5% of cases were light users (<5 quids/day). In contrast, 56% 
of age matched controls were light users. Only 7% of controls were heavy users. 
This difference was found to be statistically significant (P-0.00) 
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TABLE- 8: OVERNIGHT USAGE 
Overnight use  CASES CONTROL TOTAL 
N % N % N % 
Never 31 31 73 73 104 52 
Occasional 30 30 18 18 48 24 
Regular 39 39 9 9 48 24 
Chi square value 38.7115 
Df  2 
P- value 0.00 (significant) 
 
 
 
Thirty nine percent of cases regularly used tobacco quid in their mouth 
during sleep, as against only nine percent of controls. 
Thirty percent of cases accept occasional use of quids during the night as 
opposed to only eighteen percent of controls. 
Thirty one percent of cases have never used quids overnight as against 
seventy three percent of controls. 
This difference is statistically significant (p-0.00). 
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 TABLE-9: AVERAGE TIME PER QUID USE 
Average time per 
quid 
CASES CONTROL TOTAL 
N % N % N % 
Less than half an 
hour 
3 3 49 49 52 26 
Half to 1 hour 59 59 46 46 105 52.5 
More than 1 hour  38 38 5 5 43 21.5 
Chi square value 67.6274 
Df  2 
P- value 0.00 (significant) 
 
59% of cases kept quid in oral cavity for half to 1 hour, 38% for > 1 hour. 
In controls, 49% used for < half an hour, 46% for half to 1 hour. This was 
statistically significant. 
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TABLE-10: BIDI USE 
Bidi use CASES CONTROL TOTAL 
N % N % N % 
Never 48 48 80 80 128 64 
occasional 24 24 7 7 31 15.5 
regular 28 28 13 13 41 20.5 
Chi square value 22.8104 
Df  2 
P- value 0.00 (significant) 
 
There was 80% non-bidi user in control as compared to 48% in cases and 
regular users were higher in cases (28%) than in controls (13%). This was 
statistically significant.  
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TABLE-11: CIGARETTE USE 
Cigarette  use CASES CONTROL TOTAL 
N % N % N % 
Never 58 58 61 61 119 59.5 
occasional 37 37 25 25 62 31 
regular 5 5 14 14 19 9.5 
Chi square value 6.6614 
Df  2 
P- value 0.03 (significant) 
 
 61% of controls were non-cigarette users, 25% occasional and 14% 
regular users. In cases, 58% were non users, 37% occasional and 5% regular 
users. This difference was statistically significant. 
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TABLE-12: ALCOHOL USE 
Alcohol  use CASES CONTROL TOTAL 
N % N % N % 
Never 5 5 9 9 14 7 
occasional 43 43 72 72 115 57.5 
regular 52 52 19 19 71 35.5 
Chi square value 23.7939 
Df  2 
P- value 0.00 (significant) 
 
 
 While 72% of controls and 43% of cases were occasional alcohol users, 
19% of controls and 52% of cases were regular alcohol users. This difference 
was statistically significant. 
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 TABLE -13: OTHER SLT USE 
Other SLT  use CASES CONTROL TOTAL 
N % N % N % 
Never 46 46 71 71 117 58.5 
occasional 47 47 28 28 75 37.5 
regular 7 7 1 1 8 4 
Chi square value 14.6552 
Df  2 
P- value 0.00 (significant) 
 
The % of SLT was significantly higher than in cases 
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TABLE-14: OCCUPATION 
Occupation  CASES CONTROL TOTAL 
N % N % N % 
Clerk 16 16 32 32 48 24 
Skilled 29 29 28 28 57 28.5 
Semi-skilled 24 24 17 17 41 20.5 
unskilled 31 31 23 23 54 27 
Chi square value 7.7312 
Df  3 
P- value 0.05 (significant) 
 
  31% of cases were unskilled, 29% skilled, 24% semi-skilled and 
16% were employed as clerk. In controls, 32% were employed as clerks, 28% 
skilled and 23% unskilled workers. This was statistically significant. 
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 TABLE-15: EDUCATION 
Education  CASES CONTROL TOTAL 
N % N % N % 
Diploma 2 2 4 4 6 3 
High school 3 3 2 2 5 2.5 
Middle school 28 28 57 57 85 42.5 
Primary school 39 39 30 30 69 34.5 
Illiterate  28 28 7 7 35 17.5 
Chi square value 24.5347 
Df  4 
P- value 0.0001 (significant) 
 
 
 In cases the level of education was significantly lower than in controls. 
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TABLE-16: AWARENESS AMONG CASE VS CONTROL 
Awareness Cases (%) Control (%)       Total  
N % 
Yes 53 78 83 41.5 
No 47 22 117 58.5 
ODDS RATIO  2.87     
95% confidence interval for 
odds ratio 
Lower (1.60) Upper (5.15) 
RISK RATIO 1.86 
95% confidence interval for 
odds ratio 
Lower (1.30) Upper (2.65) 
CHI SQUARE( Mantel 
Haenszel test) 
13.7598 
P –value (2 tailed) 0.00 (significant) 
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TABLE-17: ABSTINENCE IN CASE VS CONTROL 
Abstinence Cases (%) Control (%)       Total  
N % 
Yes 54 29 131 65.5 
No 46 71 69 34.5 
ODDS RATIO  0.318                     
95% confidence interval for 
odds ratio 
Lower (0.17) Upper (0.58) 
RISK RATIO 0.67 
95% confidence interval  Lower (0.54) Upper (0.83) 
CHI SQUARE( Mantel 
Haenszel test) 
12.80 
P –value (2 tailed) 0.00 (significant) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
TABLE-18: ASSOCIATION BETWEEN AWARENESS AND NO.OF QUID 
USE IN CASE, CONTROL GROUP 
 
Group Awareness  Number of quid’s per day TOTAL% Chi-
square 
P-
value 
      <5    6-10    >10   
N % N % N % 
cases Yes 1 1.9 34 64.2 18 34 100 6.36 0.04 
(sig.) No 4 8.5 36 76.6 7 14.9 100 
control Yes 42 53.8 29 37.2 7 9.0 100 2.27 0.32 
No  14 63.6 8 36.4 0 0 100 
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TABLE-19: AGE AND STAGING ASSOCIATION 
                                                TOTAL 
 Stage-1 Stage-2 Stage-3 Stage-4 
25-35 yrs. 3 1 0 0 4 
36-45 yrs.  4 12 9 2 27 
46-55 yrs.  1 6 23 5 35 
56-65 yrs. 0 7 8 8 23 
66-75 yrs.   0 1 5 4 10 
>75 yrs. 0 1 0 0 1 
TOTAL 8 28 45 19 100 
Chi-square 50.6393 
Df 15 
P-value 0.00 (significant) 
 
 
 
 
 
 
 
 
 
 
  
 
 
DISCUSSION 
Of the 100 cases in the study, 8% belonged to stage I, 2% belonged 
to stage II, 45% belonged to Stage III, 19% belonged to stage IV. 
The most common age group affected by Squamous cell carcinoma 
of the oral cavity is between 46-55 years. An alarming thirty one percent 
of cases presented before the age of 45 years. The mean age of 
presentation in various studies is between 50 and 55 years (22). In this 
study where only tobacco quid users were taken into account, the mean 
age of presentation was 51.15 years. 
In regions where tobacco usage is highly prevalent, the mean age 
of presentation is found to be lower (approaching 35 years). In this study, 
31% of cases occurred in people younger than 45 years reflecting the 
highly prevalent usage in the community. 
Previous studies have reported an average of between 20-29 years 
of exposure to significantly increase the risk of oral cancer which is the 
combined figure is for all types of tobacco put together. In this study it 
was found the mean years of exposure in cases was 20.85 years 
specifically for tobacco quids kept in the mouth. 
 
Studies have reported that usage of more than ten quids per day 
significantly raises the risk for oral cancer (23). In this study it was found 
that cases used significantly more number of quids per day than age 
matched controls. 
Nitin Gangane et al in their paper titled “Reassessment of Risk 
Factors for Oral Cancer” (2), found history of sleeping with quid in 
mouth to be significantly more in cases. Overnight abuse translates to 
increased hours of exposure to the tobacco per day. The results of our 
study is concordant with the above study. It was observed that 39% of 
cases were regular overnight users of quid compared to only 8% among 
cases. A total of 69% of cases used to sleep with quid in mouth regularly 
or occasionally as opposed to 27% of controls who admitted to sleeping 
with quid in mouth. This finding is statistically significant and further 
strengthens the dose response relationship between tobacco quid and oral 
malignancy. 
Further strengthening the dose response relationship, is the finding 
that cases kept each quid for significantly more time in the oral cavity 
than controls. 38% of cases keep quids for more than one hour in 
comparison to only 5% of such use in controls. A majority of cases kept 
the quids for at least more than half an hour (97%) when compared to 
controls (51%). A large majority of controls usually reported spitting out 
the quid within half an hour.(49%) 
 
Multiple substance abuse is significantly more in cases when 
compared to controls. 52% of cases use bidi occasionally or on a regular 
basis when compared to controls (20%) and this result is statistically 
significant (p-0.00). While 80% of the controls have never smoked bidi, 
only 48% of cases accept to have never smoked bidi. 
When it comes to cigarette smoking, 47% of cases are regular or 
occasional users of cigarette along with tobacco quid as opposed to 
controls where only 39% have ever used cigarettes. This result was found 
to be statistically significant (0.03) 
53% of cases were regular drinkers of alcohol and 43% of cases 
were occasional alcohol drinkers (Regular drinkers being defined as 
people who have more than 3 drinks per week and Occasional drinkers 
being defined as people who take less than 3 drinks per week ) this 
difference was found to be statistically significant (P-0.00). It seems that 
regular intake of alcohol along with tobacco quid usage significantly 
increases the risk of oral malignancy. 
History of other smokeless tobacco use like mawa, gutka are 
significantly more in cases than in controls. A total of 54% of cases 
confess to occasional or regular use of other smokeless tobacco in the 
past or in the present when compared to only 29% of controls. 71% of 
controls claim to have never used other types of smokeless tobacco when 
compared to the meagre 46% of cases. Thus the usage of two or more 
types of smokeless tobacco products was significantly more in cases than 
controls (p-0.00) 
 
There is a significant difference in the occupations of cases and 
controls (p-0.05). While 55% of cases belonged to the semiskilled or 
unskilled category, only 40% of controls belonged to this category. 60% 
of controls belonged to the clerical or skilled category, while only 45% of 
cases belonged to this category. Thus cases tend to be more from semi-
skilled and unskilled group in our study. 
 
When cases and controls were taken together, only a very small 
percentage of tobacco quid users have seem to have crossed middle 
school (5% of cases and 6% of controls). Still few were diploma holders 
(25 in cases and 3% in controls).None of the subjects were graduates. 
This shows that most tobacco quid users tend to be school dropouts. 
When comparing cases and controls, 28% of cases were illiterates as 
against only 7% among controls. The educational qualification and 
literacy rate seems to be low in cases than in controls and this has been 
found to be statistically significant (p-0.0001). 
 
Awareness of the ill effects of tobacco quid seems to be more 
among cases than controls and there was a statistically significant 
difference (p-0.00). 78% of controls are aware of the ill effects of tobacco 
as compared to 53% among cases, the Odds Ratio being 2.87. 
There is a high percentage of abstinence among cases than 
controls. 54% of cases show history of abstinence for the past one year or 
more when compared to only 29% of controls, the Odds Ratio being 
0.318(p-0.00). 
Given that the controls are more aware about the ill effects of 
tobacco quid than cases the abstinence rate should be more among 
controls. But in this study it is actually the reverse. This can be attributed 
to the fact that cases tend to get scared once they develop a malignant or 
premalignant lesion and this fear drives them to abstain. While the 
controls who have not experienced any ill effects so far will continue to 
use tobacco quid.  
 
There was a significant association between age at presentation and 
stage of the disease. Younger patients (particularly those < 45 years) tend 
to present with less advanced disease and at an earlier stage when 
compared to old patients. 
 
 
 
 
 
 
 
 
 
 
 
  
LIMITATIONS 
 
• Small sample size precludes us from inferring causality and can merely 
show associations. 
• Cross sectional nature didn’t allow us to assess the nature and effect of 
trend over time. 
• We have not quantified the usage of tobacco, hence dose response 
relationship of these risk factors cannot be demonstrated. 
• Our study relies exclusively on the verbal report given by patient with 
possible chance of recall bias or underreporting. 
• The study recruited normal subjects from hospital. It would be more 
prudent to choose non- cancer relatives of patients who would share 
common genetic and environmental risk factors, more likely than with 
general population to minimise the effect of these confounding variables 
in future studies. 
• Female subjects were not recruited and there is high abuse of non-
smoking tobacco in females in India. 
 
CONCLUSION 
In this study an attempt has been made to study the abuse patterns 
of oral tobacco quid in patients with oral cancer. Numerous studies have 
in the past taken into account all types of smoking and non-smoking 
tobacco products in order to ascertain the role of each type of tobacco in 
causing oral squamous cell carcinoma with majority concluding that paan 
tobacco chewing is the most important type of tobacco contributing  to 
malignancy India. 
This study specifically concentrated on people who predominantly 
kept quid in mouth instead of chewing. With the changing pattern of 
tobacco use, with chewers becoming less and less common , there is a 
need to reassess the epidemiology of oral cancer with respect to these 
recent tobacco products. 
The study has found that a person who has oral cancer and 
primarily uses tobacco quids tends to use it more frequently, for longer 
periods of time than and is more likely to consume alcohol, cigarettes and 
bidis on a regular basis. These aspects were shown to be statistically 
significant. 
 
 
This stresses the synergistic role of alcohol in the disease causation.  
With tobacco use becoming more and more prevalent in India with 
lot of social and medical implications, the need to curb the 
manufacturing, marketing and use of these products is more than ever. 
The disfigurement and loss of function caused by oral cancer, its 
treatment, the number of life years lost due to the disease and the ever 
growing incidence of Oral squamous carcinoma in our country point to 
the fact that we need an effective national policy to identify, treat and 
rehabilitate these patients. The benefits of early diagnosis and treatment 
are well known. With new techniques being developed to identify even 
clinically silent dysplastic changes in the oral mucosa it becomes easier to 
curb the disease at a very early stage. 
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MASTER CHART  - CASES 
NAME AG
E 
SE
X 
STAG
E 
YEARS 
OF 
EXPOSU
RE 
NO 
OF 
QUID
S / 
DAY 
OVERNIG
HT USE 
AVERA
GE 
TIME 
PER 
QUID 
BI
DI 
CIGARET
TE 
ALCOH
OL 
OTHE
R SLT 
PROFESSI
ON 
EDUCATI
ON 
AWAREN
ESS 
ABSTINEN
CE 
Rathinam 55 M 3 21 2 2 2 1 2 2 1 6 6 2 1 
Kuppusamy 37 M 2 18 2 3 2 1 2 2 1 4 5 1 1 
Narayanan 64 M 4 24 3 1 3 2 1 2 2 4 6 2 1 
Eswaran 47 M 3 23 2 3 2 1 1 2 2 5 6 1 1 
Kannaippan 49 M 3 15 2 2 2 2 3 2 3 6 7 2 2 
Dilli Babu 49 M 3 17 2 2 2 1 2 3 1 3 6 1 2 
Govindasamy 60 M  4 30 1 1 2 2 1 2 1 3 7 2 2 
Vinayagam 47 M 3 22 2 2 2 1 2 3 1 4 6 2 2 
Moorthy 42 M 4 22 3 3 2 2 1 3 1 6 6 2 2 
Ravi 40 M 3 21 2 3 2 1 2 2 1 4 5 1 1 
Munusamy 59 M 4 39 1 1 2 3 1 2 1 5 7 2 2 
Kovilpicchai 56 M 2 28 2 1 3 3 1 2 2 5 7 2 2 
Anthoni 42 M  3 10 3 3 2 2 1 2 1 4 6 1 1 
Venlataramal
u 
59 M 3 29 1 1 2 3 1 3 2 5 7 2 2 
Mangesh 41 M 2 10 2 2 3 1 2 3 1 3 3 1 1 
Ellammal 52 F 3 22 2 1 2 1 1 2 1 3 7 2 2 
Karmegam 49 M 2 24 2 2 2 3 1 3 1 5 6 2 1 
Chakavarthy 56 M 4 26 1 1 2 3 2 2 1 3 6 1 1 
Shanmugavel 64 M 3 24 2 1 2 2 1 2 2 3 7 1 1 
Thirupathy 42 M 2 10 2 3 2 1 2 3 1 3 5 1 1 
Suresh 40 M 3 15 2 2 3 1 2 2 2 4 6 1 1 
Ravaniah 50 M 3 25 2 2 2 2 1 2 2 6 7 1 1 
boopathy 48 M 3 20 3 2 2 1 2 3 1 3 6 2 1 
Thanigachala
m 
57 M 2 22 2 1 2 2 1 2 2 5 6 1 1 
kuppusamy 65 M 4 20 2 1 3 3 1 2 2 5 7 1 1 
David 49 M 3 19 2 3 3 1 3 3 2 6 5 2 2 
Muivel 53 M 3 18 2 2 2 3 1 3 2 5 6 2 2 
parthasarathy 46 M 4 15 3 3 3 1 2 2 1 3 3 1 1 
Baskar 49 M 2 12 2 1 2 1 2 3 1 3 5 1 1 
Rathinam 70 M 4 30 2 2 2 3 1 2 2 6 7 2 2 
Duraikannu 53 M 3 22 2 1 2 3 1 2 2 6 6 1 2 
Pencilamma 52 F 3 20 2 1 2 1 1 1 2 6 7 2 2 
Venkatesan 47 M 3 12 2 3 3 1 2 3 2 3 5 1 1 
Pratap 48 M 2 11 2 2 3 3 2 3 2 4 5 1 1 
Sekar 45 M 3 15 2 3 3 1 2 3 2 3 5 1 1 
Arunachalam 58 M 3 21 2 3 2 3 1 3 2 6 7 2 2 
tirupathi 36 M 2 10 2 3 2 1 2 3 2 4 5 1 1 
Gopal 37 M 2 9 3 3 2 1 2 3 1 4 4 1 1 
Rana singh 50 M 4 20 2 2 2 2 1 3 2 4 6 2 2 
Kumaresan 34 M 2 12 2 3 3 1 2 2 3 5 6 1 2 
Bhola 37 M 2 15 2 3 3 1 1 2 2 4 6 2 2 
Pakkiri 54 M 4 24 2 1 2 3 1 3 2 6 7 2 2 
Muthusamy 58 M 4 29 2 1 2 3 1 3 2 5 7 2 2 
Paramasivam 48 M 4 15 2 2 3 3 1 3 2 3 6 2 2 
Lourdusamy 66 M 3 30 2 1 3 2 1 2 1 5 7 2 2 
Venkatamma 55 F 3 25 2 1 2 1 1 1 3 6 7 2 2 
Johnson 48 M 3 26 3 3 3 2 1 3 1 4 6 1 1 
Govindaraj 45 M 2 25 2 3 3 2 1 3 2 4 5 1 1 
Jagadeesan 62 M 3 30 1 1 3 3 1 3 2 6 7 2 2 
Sakthivel 39 M 2 12 2 3 3 1 2 3 1 4 5 1 1 
Janagaraj 38 M 1 10 2 3 3 1 2 3 1 4 5 1 1 
Kannan 63 M 3 32 2 1 2 3 1 3 3 6 7 2 2 
Malathiri 55 M 3 30 3 2 2 3 1 3 2 4 6 1 2 
Srinivasan 34 M 1 14 3 3 3 1 2 3 1 5 5 1 1 
Datchinamoor
thy 
51 M 4 26 2 3 2 2 1 3 2 5 5 2 2 
Duraikannu 44 M 3 17 2 3 2 3 1 3 2 6 6 2 1 
Manikkam 47 M 3 25 2 3 3 1 2 3 2 4 5 1 1 
Subramani 66 M 3 30 2 2 3 3 1 2 2 6 7 2 2 
Palsami 70 M 4 25 3 1 3 3 1 3 2 3 7 2 2 
Siprang 35 M 1 9 2 3 3 1 3 3 1 4 4 1 1 
Mohan lal 39 M 1 20 2 3 3 1 1 2 3 4 6 2 2 
Senthil 38 M 2 12 2 2 2 1 2 3 1 5 5 1 2 
Kamalakanna
n 
60 M 3 26 2 1 2 3 1 3 1 6 6 2 1 
Johnson 40 M 3 15 2 3 2 1 2 3 1 3 5 1 1 
Murugan 46 M 3 16 3 2 2 1 2 3 2 4 6 2 2 
Krishnaveni 57 F 2 23 2 1 1 1 1 1 2 6 7 2 2 
Dharani 58 M 2 15 3 1 3 3 1 2 2 5 6 1 1 
Anjalai 55 F 2 23 2 1 3 1 1 1 3 6 7 2 2 
Pattabiram 39 M 2 14 2 1 3 1 2 3 1 4 5 1 1 
Chandrasekar 69 M 2 29 2 2 2 3 2 3 2 6 7 2 1 
Subburaj 50 M 3 19 3 3 2 2 1 2 2 5 6 1 1 
Alexander 55 M 3 20 2 2 2 1 2 3 1 3 5 1 1 
Joseph 40 M 3 14 3 3 2 2 1 3 2 4 6 1 2 
Pechiappan 72 M 4 34 2 3 3 3 1 3 2 5 7 2 2 
Rajendran 75 M 3 30 2 2 2 3 1 3 1 5 7 2 1 
Arulraj 46 M 1 20 3 3 3 1 2 3 2 4 5 1 1 
Chellappa 36 M 2 14 3 2 2 1 2 2 1 4 5 1 1 
Rajagopal 42 M 4 20 2 3 2 1 2 3 1 4 5 1 1 
Kandasamy 60 M 3 28 2 2 2 3 1 2 1 6 6 1 2 
Marisamy 55 M 3 16 2 1 3 2 1 3 2 6 7 2 1 
Imanullah 45 M 3 17 2 2 2 1 2 1 1 4 6 1 2 
Vijayarajan 61 M 4 26 2 2 3 2 1 2 2 6 6 1 2 
Ravi 29 M 1 12 3 3 3 1 1 2 2 4 6 1 2 
Ratnahar 
Sahoo 
48 M 2 18 2 3 3 1 2 2 1 6 6 2 2 
Thulukannam 64 M 4 24 3 2 3 2 1 2 1 6 7 2 2 
Iyappan 50 M 3 20 2 3 2 1 2 3 1 5 6 1 2 
Surendran 42 M 1 15 3 3 3 3 1 2 2 6 6 1 1 
Kulasekaran 56 M 2 22 3 2 2 1 2 3 1 6 6 1 1 
Lingasamy 60 M 2 24 2 1 2 2 1 2 1 6 6 2 2 
Muthukannan 75 M 2 35 3 2 2 2 1 2 2 6 6 2 1 
Jayaraman 72 M 3 37 2 2 2 3 1 2 1 6 6 2 1 
Mayalagu 68 M 3 34 2 1 2 2 1 2 1 5 7 1 1 
Alagiri 45 M 3 24 3 1 3 1 2 2 1 4 5 1 1 
Gurunathan 61 M 3 31 3 1 2 2 1 2 1 6 5 1 1 
Saravana 
babu 
43 M 2 17 2 3 3 1 3 2 1 4 5 2 1 
Janakiraman 50 M 3 17 2 3 1 1 2 2 3 5 5 2 2 
Ezumalai 36 M 1 10 2 3 2 1 1 3 2 5 5 1 1 
Venu 47 M 2 13 3 3 1 2 3 3 1 5 4 1 1 
Chidambaram 72 M 4 30 2 1 2 2 1 2 2 6 5 2 2 
Sivasilam 47 M 2 16 3 2 2 1 1 3 1 5 6 1 1 
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Chinnathamb
i 
52 M 15 1 1 1 1 1 2 1 5 6 1 1 
Balachandran 37 M 10 2 1 2 1 1 1 1 4 5 1 2 
Jerald Raj 65 M 17 1 1 1 1 1 2 2 3 5 2 1 
Kannippan 46 M 12 1 1 2 1 1 2 2 5 6 1 2 
Sekar 49 M 10 2 2 1 1 2 2 1 5 7 1 2 
Muugan 48 M 9 1 1 1 1 2 2 1 3 5 1 2 
Jaganathan 59 M  24 1 1 1 2 1 2 2 3 7 1 2 
Pandurangan 49 M 12 2 1 1 1 1 2 1 3 6 2 2 
Gnanam 42 M 12 2 3 2 1 1 3 1 4 5 1 2 
Vadivel 44 M 11 2 1 1 1 2 2 1 4 5 1 2 
Jayabalan 59 M 26 2 1 1 1 1 2 1 6 5 1 2 
Bakiaraj 56 M 14 1 1 3 1 1 2 2 5 7 2 2 
Dhandayutha
pani 
44 M  5 2 2 1 2 3 2 1 3 6 1 2 
Elango 59 M 20 1 2 1 1 1 2 2 3 5 1 2 
Muralimohan 42 M 15 1 2 1 1 1 3 1 3 3 1 1 
Janagaraj 52 M 26 1 1 2 1 1 1 1 3 7 1 2 
Adhimoolam 48 M 24 2 1 2 1 1 2 1 3 5 2 2 
Nandakumar 57 M 20 1 2 1 1 1 2 1 3 6 1 1 
Dharman 62 M 14 2 1 2 1 1 2 1 3 7 1 1 
Paramasivam 45 M 10 3 1 1 1 2 2 1 3 5 1 2 
George 42 M 10 1 1 3 1 2 2 1 3 5 1 2 
Shenbagaraj 49 M 25 1 1 1 2 1 2 1 6 5 1 1 
Subbu 47 M 11 2 2 2 1 1 3 1 3 6 1 2 
Balaraman 57 M 11 2 1 1 1 1 2 2 3 6 1 1 
Arunachalam 63 M 10 1 1 1 3 1 3 1 5 5 1 2 
Vasanthan 49 M 12 1 1 3 1 1 3 2 4 5 1 2 
Vijayakumar 55 M 14 1 1 1 1 1 1 1 5 6 2 2 
Sukumar 48 M 11 2 2 1 1 1 2 1 3 3 1 2 
Mahohar 54 M 12 1 1 2 1 2 1 1 3 5 1 1 
Annasami 73 M 30 2 1 1 1 1 2 1 4 5 1 2 
Nataraj 55 M 25 1 1 2 3 3 2 2 3 6 1 2 
Kalyanarama
n 
52 F 10 1 1 2 1 1 1 2 3 5 1 2 
Laxmanan 45 M 12 1 3 2 1 1 2 1 3 5 1 1 
Arokiya raj 48 M 5 1 1 2 1 2 2 1 4 5 1 1 
Ponnusamy 47 M 10 1 1 2 1 2 2 2 3 5 1 2 
Saravanan 56 M 12 1 3 2 3 1 3 1 6 5 1 2 
Gurunathan 38 M 10 2 1 1 1 2 2 1 3 5 1 2 
Krishnakuma
r 
36 M 4 1 1 2 1 1 3 1 4 4 1 1 
Danuskodi 49 M 8 2 2 2 1 1 2 2 4 4 1 2 
Balaji 34 M 7 2 1 1 1 3 2 1 3 6 1 2 
Sambandham 35 M 15 1 1 1 1 1 2 2 4 6 2 2 
Rajaram 55 M 20 1 1 2 3 1 3 1 6 5 1 2 
Soolai 56 M 20 1 1 2 1 1 2 2 5 5 2 2 
Chakrabani 48 M 10 1 2 1 3 1 3 1 3 6 1 2 
Kandhan 67 M 30 2 2 2 1 1 2 1 4 5 2 2 
Sudagar 55 M 14 2 3 2 1 3 1 1 4 7 1 2 
Madhusoodh
anan 
46 M 16 2 3 1 2 1 3 1 4 5 1 1 
Marudhamut
hu 
45 M 13 3 1 3 1 1 2 1 4 5 1 2 
Sekar 62 M 17 3 1 1 3 1 2 2 5 5 1 2 
Nagendran 39 M 12 2 3 1 1 1 2 1 4 5 1 1 
Palanivel 64 M 5 1 1 1 1 2 2 1 3 5 1 2 
Chiokkalinga
m 
63 M 20 1 1 2 3 1 3 1 6 5 1 2 
Gnanaraja 52 M 15 3 2 1 1 3 2 2 4 6 1 2 
Kumaresan 34 M 10 1 1 1 1 1 2 1 5 5 1 2 
Mani 52 M 13 1 3 2 1 1 2 2 5 5 2 2 
Anandan 44 M 13 2 3 1 3 3 2 1 6 5 1 1 
Santhanam 45 M 12 2 1 3 1 1 2 2 4 5 1 2 
Thangappan 66 M 15 1 1 1 1 1 2 2 6 7 2 2 
Sitaraman 72 M 19 2 1 1 3 3 3 1 3 5 2 2 
Vellappan 35 M 10 2 1 1 1 1 2 1 4 3 1 1 
Rasiah 37 M 10 1 2 2 1 1 2 3 4 3 2 2 
Appukutty 38 M 12 2 1 1 1 3 2 1 5 5 1 2 
Thirumalai 60 M 26 1 1 1 1 1 2 1 6 5 2 1 
Mari 42 M 15 2 1 2 1 2 3 1 4 5 1 1 
Iyyanar 48 M 16 2 2 1 1 2 2 1 4 6 2 2 
Purusothama
n 
57 M 17 2 1 1 1 1 1 2 6 6 2 2 
Thyagarajan 59 M 14 1 1 1 1 2 2 1 6 6 1 1 
Somu 52 F 17 1 2 1 1 2 1 1 6 6 1 2 
Parattai 36 M 14 2 1 1 1 2 2 1 4 5 1 1 
janakiraman 67 M 18 1 1 2 3 2 2 2 6 6 2 2 
Parthiban 49 M 10 2 1 2 1 1 2 1 5 6 1 1 
Sasikumar 53 M 20 2 2 2 1 2 3 1 3 5 1 1 
Palpandi 41 M 10 1 1 2 1 1 3 2 4 6 1 2 
Kumaresan 76 M 34 2 1 2 3 1 2 2 5 6 2 2 
Ragu 75 M 32 1 2 2 1 1 3 1 5 6 1 2 
Manohar 46 M 22 1 1 2 1 2 2 2 4 5 1 1 
Viswanathan 35 M 19 1 1 2 1 2 2 1 5 5 1 2 
Balaji 44 M 20 2 1 2 1 2 2 1 4 5 1 1 
Sonasalam 61 M 13 1 1 2 3 1 2 1 6 6 1 2 
Kandasami 54 M 15 1 1 2 2 1 2 2 6 6 1 2 
Ramamoorth
y 
44 M 13 2 1 1 1 1 1 1 4 6 1 2 
Ravi 59 M 26 1 1 2 1 1 2 2 3 6 1 2 
Thiyagu 30 M 14 1 1 2 1 1 2 2 4 6 1 2 
Muniswaran 48 M 10 2 1 2 1 2 2 1 6 5 2 2 
Baskar 64 M 14 1 2 2 1 1 2 1 6 5 1 2 
Narayanan 54 M 10 2 3 2 1 2 2 1 3 6 1 2 
Khonba 40 M 15 3 1 1 1 3 2 1 6 5 1 1 
Lingam 57 M 22 2 1 2 1 2 2 1 6 6 1 2 
Ritesh 62 M 14 1 1 2 1 1 2 1 6 5 2 2 
Sridhar 72 M 20 1 2 1 1 1 2 2 6 5 1 1 
Kannan 72 M 21 1 1 2 3 3 2 1 6 6 2 1 
Picchiah 66 M 23 1 1 2 1 1 2 1 3 5 1 2 
Suresh 42 M 16 3 1 2 1 2 2 1 4 5 1 1 
Paneerselvam 61 M 19 1 1 1 2 3 2 1 6 5 1 1 
Gemini 41 M 7 1 1 1 1 3 2 1 4 5 2 2 
Pratap 52 M 8 1 1 1 1 2 2 1 3 5 1 2 
Venkatagiri 39 M 5 1 1 2 1 1 3 2 5 5 1 1 
Arumugam 45 M 5 3 1 1 1 3 3 1 5 5 1 2 
Divagar 74 M 15 1 1 1 2 1 2 1 6 5 2 2 
Ganesan 46 M 10 1 1 1 1 3 3 1 3 5 1 2 
 
